PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Central Laboratory, Longgang Distract People\'s Hospital of Shenzhen & The Third Affiliated Hospital (Provisional) of The Chinese University of Hong Kong, Shenzhen, China.\', \'Shenzhen Key Laboratory of Infection and Immunity, Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People\'s Hospital, Shenzhen, China.\', \'Department of Emergency, People\'s Hospital of Leling, Dezhou, Shandong, China.\', \'Department of Medical Cell Biology and Genetics, Guangdong Key Laboratory of Genome Stability & Disease Prevention, Shenzhen Key Laboratory for Anti-ageing and Regenerative Medicine, Health Science Center, Shenzhen University, Shenzhen, China.\', \'Laboratory of Experimental Cardiology, Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.\', \'Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250100, Shandong, China. Electronic address: zhiyi_yu@sdu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)32556-X10.1016/j.ijid.2020.12.033
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33333250
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A high-throughput drug screening strategy against coronaviruses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all